hotspot -WSS

hotspot

author：focus 2025-09-29 02:46:39 - browse：95

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： How neuroscience research could help beat back brain cancer

entertainment

hotspot

WSS

Divers poised to search for children washed away in Pennsylvania flash flood

Stanford president's case begs question: Who takes blame?

The health care issue Democrats can’t solve: hospital reform

Key Senate panel to consider PBM, drug pricing reform package

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Gene therapy’s promise and the high cost of hope

hotspot

hotspot

Wikipedia

https://cbu01.alicdn.com/img/ibank/2017/783/713/4465317387_1615316879.220x220xz.jpg

Driven by the pandemic, applicants flood public health schools

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Bill would allow buprenorphine prescription for addiction via telehealth

Psychedelics group wrestles with new pharma identity

Inari Medical to buy amputation prevention company LimFlow

Walensky prepares to leave CDC — and Congress — behind

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Medicare details structure of new drug price negotiation program

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

focus

After Sarepta trial failure, Duchenne families brace for more debate

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Stanford president faces new allegations over 1999 paper

Stanford president faces new allegations over 1999 paper

Ending racial health disparities hinges on penalties, political will

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

entertainment

hotspot

explore

knowledge